HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shiguo Zhu Selected Research

Ligands

3/2015The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells.
7/2013Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shiguo Zhu Research Topics

Disease

20Neoplasms (Cancer)
01/2022 - 07/2003
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 11/2017
5Lung Neoplasms (Lung Cancer)
01/2021 - 10/2016
3Neoplasm Metastasis (Metastasis)
01/2020 - 07/2007
2Ischemic Stroke
01/2021 - 01/2018
1Bites and Stings (Sting)
01/2022
1Melanoma (Melanoma, Malignant)
01/2022
1Pain (Aches)
01/2020
1Neuralgia (Stump Neuralgia)
01/2020
1Brain Ischemia (Cerebral Ischemia)
01/2018
1Brain Injuries (Brain Injury)
01/2018
1Brain Infarction
01/2018
1Ischemia
01/2018
1Carcinoma (Carcinomatosis)
03/2015
1Sarcoma (Soft Tissue Sarcoma)
03/2015
1Osteosarcoma (Osteogenic Sarcoma)
03/2015
1Lymphoma (Lymphomas)
07/2014
1Inflammation (Inflammations)
07/2014
1Carcinogenesis
07/2013
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2013
1Interstitial Cystitis (Interstitial Cystitis, Chronic)
01/2012
1Nasopharyngeal Carcinoma
09/2003

Drug/Important Bio-Agent (IBA)

7DNA (Deoxyribonucleic Acid)IBA
02/2014 - 07/2007
6Biological ProductsIBA
01/2022 - 01/2015
4Proteins (Proteins, Gene)FDA Link
01/2020 - 07/2007
4CytokinesIBA
01/2020 - 01/2008
4Interleukin-12 (IL 12)IBA
02/2014 - 07/2007
2rocaglamideIBA
01/2022 - 01/2018
2InterferonsIBA
01/2022 - 01/2018
2MicroRNAs (MicroRNA)IBA
03/2021 - 01/2020
2LigandsIBA
03/2015 - 07/2013
2Complementary DNA (cDNA)IBA
01/2015 - 09/2003
2Doxorubicin (Adriamycin)FDA LinkGeneric
02/2014 - 07/2007
2Complement System Proteins (Complement)IBA
05/2008 - 05/2008
2Peptides (Polypeptides)IBA
05/2008 - 05/2008
1RNA (Ribonucleic Acid)IBA
01/2022
1Mitochondrial DNA (mtDNA)IBA
01/2022
1cyclic guanosine monophosphate-adenosine monophosphateIBA
01/2022
1rediocide AIBA
12/2021
1Immune Checkpoint InhibitorsIBA
12/2021
1Adrenergic Agents (Adrenergic Drugs)IBA
01/2021
1astragaloside AIBA
01/2021
1tanshinoneIBA
01/2021
13-ingenyl angelateIBA
12/2020
120-deoxyingenolIBA
12/2020
1EndorphinsIBA
01/2020
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2020
1Analgesics (Analgesic Drugs)IBA
01/2020
1LuciferasesIBA
01/2019
1buyang huanwuIBA
01/2018
1GelatinIBA
01/2018
1Evans Blue (Blue, Evans)FDA Link
01/2018
1Tight Junction ProteinsIBA
01/2018
1Messenger RNA (mRNA)IBA
01/2018
1Chemokine CXCL10IBA
01/2018
1NF-kappa B (NF-kB)IBA
01/2018
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2018
1Indicators and Reagents (Reagents)IBA
11/2017
1ailanthoneIBA
11/2017
1ingenolIBA
01/2017
1IsoenzymesIBA
01/2017
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
01/2017
1Phosphotransferases (Kinase)IBA
01/2017
1Antineoplastic Agents (Antineoplastics)IBA
10/2016
1sanguinarineIBA
10/2016
1micaIBA
03/2015
1Histones (Histone)IBA
03/2015
1entinostat (MS 275)IBA
03/2015
1benzamideIBA
03/2015
1Histone Deacetylase InhibitorsIBA
03/2015
1interleukin-21 (interleukin 21)IBA
07/2014
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
07/2014
1NK Cell Lectin-Like Receptor Subfamily KIBA
02/2014
1Immunoglobulins (Immunoglobulin)IBA
07/2013
1KIR ReceptorsIBA
07/2013
1Membrane Proteins (Integral Membrane Proteins)IBA
07/2013
1Natural Killer Cell ReceptorsIBA
07/2013
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2012
1Interleukin-27 (Interleukin 27)IBA
03/2010
1STAT1 Transcription FactorIBA
07/2007
11,3- dihydroxy- 4,4,5,5- tetramethyl- 2- (4- carboxyphenyl)tetrahydroimidazole (NOR 1)IBA
07/2003

Therapy/Procedure

11Immunotherapy
01/2022 - 07/2013
3Chinese Traditional Medicine (Traditional Chinese Medicine)
12/2021 - 04/2019
2Therapeutics
01/2021 - 01/2020
1Acupuncture Points (Acupuncture Point)
01/2021
1Moxibustion
01/2021
1Electroacupuncture
01/2020
1Intraperitoneal Injections
02/2014